retatrutide triple agonist gip glp-1 glucagon phase 2 obesity trial Retatrutide's mechanisms of action New GLP-3 drug significantly slashes
Description
- Oral semaglutide is effective, safe and well tolerated in patients with DM2, even in those with DKD, with the benefits inherent to this family of drugs, which may facilitate the earlier introduction of an arGLP-1 in the management of DM2
ox-LDL: oxidized-LDL
however, pediatric obesity exhibits a different physiology
Idiopathic Intracranial Hypertension (Pseudotumor Cerebri) Increased pressure in the skull without a tumor causing headaches and vision problems
